Jamie Blundell, group leader (2017 - present). [CV][Twitter][SCHOLAR]  

Jamie is the Ursula Zoellner Professor of Cancer Research at the University of Cambridge. He trained as a theoretical physicist at the Cavendish Laboratory, University of Cambridge with Eugene Terentjev studying the statistical physics of polymers. He moved to Stanford University in 2012 as a postdoctoral scholar working on the dynamics of clonal evolution with Daniel Fisher, Sasha Levy, Dmitri Petrov and Gavin Sherlock. He joined the Early Cancer Institute in July 2017 and was awarded a UKRI Future Leaders fellowship in September 2019. His research interests lie in quantitatively understanding somatic evolution and adaptive immunity. He is also the Anthony L. Lyster fellow at Queens’ College.

Gladys poon, postdoc (2022- present)

Gladys graduated from the University of Cambridge with a BA and M.Sci in Physics in 2018 and stayed on to do a PhD in early cancer detection in the Blundell Lab. Her research focuses on applying quantitative insights to biological problems.

Jinqi Fu, postdoc (2018 - present)

Jinqi received her BSc in Veterinary Medicine from Qingdao Agricultural University and then moved to China’s CDC to complete her MSc on developing a universal vaccine against influenza A virus. She then obtained her PhD from the Department of Veterinary Medicine, University of Cambridge where she worked on developing a novel DNA barcoding system to investigate transmission dynamics of influenza A viruses among pig populations. Jinqi is working on using longitudinal TCR repertoire profiling as a possible early cancer detection tool.

adriana fonseca, Postdoc (2023 - present)

Adriana graduated with an MSci in Genetics from the University of Glasgow in 2018. Following that, she studied on the CRUK Cambridge Centre MRes+PhD programme in cancer biology. From October 2023, Adriana was granted an ACED Early Career Pathway Award. Her work focuses on applying deep error-correctable methylation sequencing to longitudinal samples to understand the dynamics of methylation during healthy ageing and how they are altered in the earliest stages of cancer.

Iñigo ayestAran, phd student (2019 - present)

Iñigo is a computational biologist. He graduated from the computational biology masters programme in Cambridge in 2016 and then worked as a staff bioinformatician in Steve Jackson’s lab for 2 years. Iñigo joined the lab in 2019, funded by an MRC DTP studentship. His project is focused on using statistical changes in T-cell receptor repertoires in the peripheral blood tracked over time to detect cancer at its earliest stages.

Hamish macgregor, PhD student (2020 - present)

Hamish graduated in theoretical physics from the University of Cambridge in 2020. He is jointly supervised by Doug Easton in the Centre for Cancer Genetic Epidemiology on a studentship supported by the ACED alliance. Hamish’s PhD project centres around using methods from population genetics to better distinguish germline variants from somatic variants in large collections of blood-derived exomes e.g. UKBiobank or Bridges and understanding how clonal haematopoiesis changed throughout the human lifespan, including childhood.

Shoko Hirosue, PhD student (2021 - present)

Shoko received her MB from the University of Cambridge in 2023 and is continuing as a PhD student in the lab. Her PhD project, jointly supervised by Dr Sakari Vanharanta, involves transcriptional and epigenetic state transitions in early renal carcinogenesis.

vasilis stavrinides, visiting researcher (2022 - present)

Vasilis is a medical doctor who did his junior surgical training in Oxford and London before completing a PhD in cancer imaging at UCL. He has MSc degrees in Molecular Biology and Applied Statistics and is currently investigating the longitudinal dynamics of MRI-visible, early-stage prostate cancer. He is the principal investigator for a number of grants and is visiting the lab on the CRUK-ACED Skills Exchange and Development Travel Award to learn basic DNA sequencing techniques that can be applied to patient-derived material.

DANNY TEMKO, Visiting Researcher (2023 – present)

Danny is a Research Associate at the MRC Biostatistics unit. He has an undergraduate degree in mathematics and philosophy from Oxford and a PhD in computational biology from UCL. As a visitor in the lab, Danny is interested in using the tools of statistical inference to dissect the different levels of determinism and chance that shape cancer development.

CHRISTOPHER BONIFACE, POSTDOC (2023 - PRESENT)

Chris earned his BA in Biochemistry and Molecular Biology from Reed College in Portland, Oregon, USA. He obtained his PhD in Cancer Biology and Early Detection from Oregon Health & Science University School of Medicine (Portland, Oregon, USA), where he developed novel molecular barcoding techniques and computational error-modelling approaches to detect low-abundance mutations in DNA using next-generation sequencing of early- and late-stage cancer patients. He also developed methods for inferring subclonal dynamics, clonal selection, and mechanisms of resistance by longitudinally measuring circulating tumour DNA (ctDNA) abundance at many alleles during cancer therapy.

Akemi RamoS, research assistant (2023 - present)

Akemi has a background in genetics and her main interest is using machine learning with genomics data for precision medicine. She first joined us as a Masters student studying Computational Biology at Cambridge, and applied machine learning methods on whole genome and targeted methylation data to build a classifier for Acute Myeloid Leukaemia (AML) and discover regions of the genome useful for AML diagnosis. Akemi will stay at the Blundell lab next year as a PhD candidate, supported by ACED.

Sam Hackett, research assistant (2023 - present)

Sam graduated from the University of Cambridge with a BA in Physics and a MMATH in Mathematics. He is interested in building mathematical and computational models for TCR clonal dynamics.

Barbara Walkowiak, Masters student (2023 - Present)

Barbara is studying Biological Natural Sciences at Cambridge. She specialised in Genetics, and is currently pursuing a Masters in Systems Biology. She is interested in the role of the immune system in shaping the dynamics of clonal haematopoiesis.

shelly evans, phD student (2023 - present)

Shelley received a B.MSc. from La Trobe University, Australia where her honours year project focused on the regulation of the BH3-only protein, BIM. She then went on to work for a start up company, Hexima ltd, looking at non-chemical pest control for food crops. After moving to the UK, she worked in accounts/admin, then haematological diagnostics, before becoming a research assistant in the Pathology department at the university of Cambridge, looking at TCR repertoire changes in response to disease. Her PhD is jointly supervised by Prof. Liz Soilleux and is focused on TCR repertoire profiling.

Abi colley, Phd student (2024-present)

Abi graduated in Natural Sciences from the University of Cambridge in 2023, specialising in Pathology. She is on the CRUK Cambridge Centre MRes+PhD program in cancer biology. Her PhD project focuses on fine-scale mapping of TCR-antigen interactions with a view to optimising TCR sequences for adoptive T cell therapies.

Yishan pan, summer research student (2024)

Yishan is an MEng Molecular Bioengineering student from Imperial College London. She joined us through 2024 CRUK Cambridge Summer Research Replacement Program, investigating the methylation of clock CpGs on pre-AML diagnosed samples for early detection.

Suraksha JAYAKUMAR, Summer research student (2024)

Suraksha joined us as a second-year undergraduate at Warwick, studying Biomedical Sciences. She worked on establishing a baseline of expected methylation changes from DNA samples collected from healthy individuals that can be compared to pre-AML case samples

James Longstaff, Summer research student (2023)

James joined us as a second-year Cambridge undergraduate studying Natural Sciences with a focus on physics. His summer project in our lab focused on understanding the statistical properties of fluctuating methylation sites and using these insights to extract methylation mutation rates from genomic data sets.

Isaac Baguley, Summer research student (2023)

Isaac joined us as a second-year undergraduate at Cambridge studying Natural Sciences with a focus on cell biology and neuroscience. He worked on mathematical modelling of 2-hit models in cancer and pre-cancer to better identify individuals harbouring double mutant clones who might be at higher risk of progression.

AMANDA TAN, Research assistant (2022 - 2023)

Amanda graduated with an MSci in Neuroscience from UCL in 2022. She joined us as a research assistant to gain further experience in biomedical research. Amanda led a research project to explore using phased long-read methylation sequencing (e.g. from Oxford Nanopore) to build phylogenies from tissue samples including blood and oesophagus. She also generated phased methylation data for deep short-read sequencing of longitudinal samples to understand how methylation dynamics is altered in early cancer.

Caroline watson, clinical research associate (2017 - 2023)

Caroline qualified in medicine from the University of Oxford in 2010 and completed her clinical training in haematology in Cambridge in 2022. Between 2017-2021, she worked as a CRUK-Clinical Research Fellow with us, generating and analysing ultra-deep sequencing data from longitudinal blood taken over decade-long timescales in healthy individuals and those who develop Acute Myeloid Leukemia. Her PhD thesis, The evolutionary dynamics of clonal haematopoiesis and its progression to acute myeloid leukaemia, was awarded the Milo Keynes PhD thesis prize. She is also a winner of the RCPath Gold medal (2020), lead PI on the LEGACY study and a widely published scientific illustrator. In 2023, Caroline was awarded a Wellcome Early Career Award and appointed as a Junior Group Leader at the Early Cancer Institute. (We’re very proud!)

YueXuan Zhang, undergraduate intern (2022 - 2023)

Yuexuan joined us during her second undergraduate year studying Natural Sciences (Biological) at Queens’ College, Cambridge with a focus on computational biology. With us, she developed computational approaches for analysing time-series data from high-depth targeted methylation sequencing. This was aimed at gaining a better understanding of methylation dynamics during healthy ageing and in the years preceding a leukaemia diagnosis. She also helped to develop our EM-seq (methylation) assay and apply it to serial blood samples.